FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2316495823> ?p ?o ?g. }

• W2316495823 endingPage "556" @default.
• W2316495823 startingPage "549" @default.
• W2316495823 abstract "Background Indication and timing of pharmacological venous thromboembolism prophylaxis in intracerebral hemorrhage patients is controversial. Aims To determine whether use of subcutaneous heparin during the first 7 days after spontaneous intracerebral hemorrhage increases risks of death and disability. Methods Data are from the Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT2) study. Patients with acute intracerebral hemorrhage (<6 hours) and elevated systolic blood pressure were included; patients received subcutaneous heparin following local best practice standards of care. Multivariable logistic regression and propensity score matched analysis were used to determine associations of heparin use on death and disability (modified Rankin scale) at 90 days. Results In 2525 patients with available data, there were 465 (22.5%) who received subcutaneous heparin. They had higher death or major disability at 90 days in crude (odds ratio 2.29, 95% confidence interval 1.85–2.84; p < 0.001), adjusted (odds ratio 1.62, 95% confidence interval 1.26–2.09; p < 0.001) and propensity score matched (odds ratio 2.06, 95% confidence interval 1.53–2.77; p < 0.001) analyses. In propensity score matched analysis, heparin-treated patients had significant lower mortality (odds ratio 0.55, 95% CI 0.35–0.87; p = 0.01) but greater major disability (odds ratio 1.68, 95% confidence interval 1.25–2.28; p < 0.001) at 90 days. However, no mortality difference was found in analysis restricted to 48-hour survivors. Conclusions Use of subcutaneous heparin is associated with poor outcome in acute intracerebral hemorrhage, driven by increased residual disability. Despite the limitations of this study, and no clear relation of heparin with bleeding risk, we recommend careful consideration of the need for venous thromboembolism prophylaxis with heparin in intracerebral hemorrhage patients. Trial registration http://www.clinicaltrials.gov NCT00716079." @default.
• W2316495823 created "2016-06-24" @default.
• W2316495823 creator A5005538880 @default.
• W2316495823 creator A5010546148 @default.
• W2316495823 creator A5025167498 @default.
• W2316495823 creator A5026830827 @default.
• W2316495823 creator A5036471971 @default.
• W2316495823 creator A5039223191 @default.
• W2316495823 creator A5045770117 @default.
• W2316495823 creator A5055394217 @default.
• W2316495823 creator A5072218240 @default.
• W2316495823 creator A5076052737 @default.
• W2316495823 date "2016-03-23" @default.
• W2316495823 modified "2023-09-30" @default.
• W2316495823 title "Prophylactic heparin in acute intracerebral hemorrhage: a propensity score-matched analysis of the INTERACT2 study" @default.
• W2316495823 cites W1603121691 @default.
• W2316495823 cites W1761464837 @default.
• W2316495823 cites W2004930264 @default.
• W2316495823 cites W2029584540 @default.
• W2316495823 cites W2036193982 @default.
• W2316495823 cites W2051866975 @default.
• W2316495823 cites W2056068526 @default.
• W2316495823 cites W2056430514 @default.
• W2316495823 cites W2087512895 @default.
• W2316495823 cites W2088113114 @default.
• W2316495823 cites W2093072754 @default.
• W2316495823 cites W2111448024 @default.
• W2316495823 cites W2114214167 @default.
• W2316495823 cites W2120086574 @default.
• W2316495823 cites W2120721286 @default.
• W2316495823 cites W2123511255 @default.
• W2316495823 cites W2126627286 @default.
• W2316495823 cites W2135533213 @default.
• W2316495823 cites W2136975742 @default.
• W2316495823 cites W2138238488 @default.
• W2316495823 cites W2141913785 @default.
• W2316495823 cites W2148305501 @default.
• W2316495823 cites W2154814156 @default.
• W2316495823 cites W2314938408 @default.
• W2316495823 cites W2548934243 @default.
• W2316495823 cites W3171831654 @default.
• W2316495823 cites W4296148784 @default.
• W2316495823 doi "https://doi.org/10.1177/1747493016641113" @default.
• W2316495823 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27009893" @default.
• W2316495823 hasPublicationYear "2016" @default.
• W2316495823 type Work @default.
• W2316495823 sameAs 2316495823 @default.
• W2316495823 citedByCount "11" @default.
• W2316495823 countsByYear W23164958232016 @default.
• W2316495823 countsByYear W23164958232017 @default.
• W2316495823 countsByYear W23164958232018 @default.
• W2316495823 countsByYear W23164958232019 @default.
• W2316495823 countsByYear W23164958232020 @default.
• W2316495823 countsByYear W23164958232022 @default.
• W2316495823 countsByYear W23164958232023 @default.
• W2316495823 crossrefType "journal-article" @default.
• W2316495823 hasAuthorship W2316495823A5005538880 @default.
• W2316495823 hasAuthorship W2316495823A5010546148 @default.
• W2316495823 hasAuthorship W2316495823A5025167498 @default.
• W2316495823 hasAuthorship W2316495823A5026830827 @default.
• W2316495823 hasAuthorship W2316495823A5036471971 @default.
• W2316495823 hasAuthorship W2316495823A5039223191 @default.
• W2316495823 hasAuthorship W2316495823A5045770117 @default.
• W2316495823 hasAuthorship W2316495823A5055394217 @default.
• W2316495823 hasAuthorship W2316495823A5072218240 @default.
• W2316495823 hasAuthorship W2316495823A5076052737 @default.
• W2316495823 hasConcept C126322002 @default.
• W2316495823 hasConcept C141071460 @default.
• W2316495823 hasConcept C156957248 @default.
• W2316495823 hasConcept C17923572 @default.
• W2316495823 hasConcept C2777094939 @default.
• W2316495823 hasConcept C2777736543 @default.
• W2316495823 hasConcept C2780931571 @default.
• W2316495823 hasConcept C3020199598 @default.
• W2316495823 hasConcept C42219234 @default.
• W2316495823 hasConcept C44249647 @default.
• W2316495823 hasConcept C541997718 @default.
• W2316495823 hasConcept C71924100 @default.
• W2316495823 hasConceptScore W2316495823C126322002 @default.
• W2316495823 hasConceptScore W2316495823C141071460 @default.
• W2316495823 hasConceptScore W2316495823C156957248 @default.
• W2316495823 hasConceptScore W2316495823C17923572 @default.
• W2316495823 hasConceptScore W2316495823C2777094939 @default.
• W2316495823 hasConceptScore W2316495823C2777736543 @default.
• W2316495823 hasConceptScore W2316495823C2780931571 @default.
• W2316495823 hasConceptScore W2316495823C3020199598 @default.
• W2316495823 hasConceptScore W2316495823C42219234 @default.
• W2316495823 hasConceptScore W2316495823C44249647 @default.
• W2316495823 hasConceptScore W2316495823C541997718 @default.
• W2316495823 hasConceptScore W2316495823C71924100 @default.
• W2316495823 hasIssue "5" @default.
• W2316495823 hasLocation W23164958231 @default.
• W2316495823 hasLocation W23164958232 @default.
• W2316495823 hasOpenAccess W2316495823 @default.
• W2316495823 hasPrimaryLocation W23164958231 @default.
• W2316495823 hasRelatedWork W2122595195 @default.
• W2316495823 hasRelatedWork W2133349947 @default.
• W2316495823 hasRelatedWork W2151375020 @default.

• next